Combination Therapy with Bupropion and Risperidone

Introduction to Combination Therapy

• The American College of Oncology suggests starting with lower risperidone doses (e.g., 0.5 mg) and titrating cautiously based on clinical response when combining with bupropion 1
• The National Comprehensive Cancer Network recommends monitoring closely for extrapyramidal symptoms (EPS) as risperidone carries increased EPS risk at doses >6 mg/24 hours, and this risk may be amplified by elevated drug levels 1

Dosing and Monitoring Considerations

• The American College of Oncology advises watching for metabolic side effects including weight gain, metabolic dysregulation, orthostatic hypotension, and sedation, which are common with risperidone and may be intensified 1, 2
• The National Comprehensive Cancer Network suggests being vigilant for seizure risk, as both medications lower the seizure threshold—bupropion is contraindicated in patients with seizure disorders or brain metastases, and combining with antipsychotics requires extreme caution 3

Contraindications and Warnings

• The American Diabetes Association notes that patients with uncontrolled hypertension are absolutely contraindicated for this combination due to bupropion's effects 4
• The National Comprehensive Cancer Network warns against using this combination in patients with seizure disorders, brain metastases, or conditions significantly lowering seizure threshold 3